Vialwirebiotech, curated
July 23, 2026, 6:47 AM
May 14, 2026
- 6:31 AM · Endpoints News6:31 AMBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta — Endpoints News
- 6:24 AM · Drug Discovery World6:24 AMMHRA to open Northern Ireland hub to boost life sciences — Drug Discovery World
- 5:00 AM · Drug Discovery World5:00 AMUK centre opens to accelerate Parkinson’s treatment research — Drug Discovery World
May 13, 2026
- 1:46 PM · Endpoints News1:46 PMValneva to cut up to 15% of jobs as reduced travel hits vaccine demand — Endpoints News
- 11:23 AM · BioPharma Dive11:23 AMLilly data point to ‘maintenance’ strategies for GLP-1 weight loss — BioPharma Dive
- 10:27 AM · BioPharma Dive10:27 AMAssertio accepts new buyout bid; AI biotech Isomorphic banks $2B — BioPharma Dive
- 9:28 AM · NYT — Science9:28 AMMarty Makary, Trump’s F.D.A. Commissioner, Resigns After Weeks of Pressure — NYT — Science
- 9:21 AM · Pharmaceutical Executive9:21 AM<![CDATA[Rigel Pharmaceuticals Enters $85 Million Agreement for Exclusive Global Rights to Veppanu]]> — Pharmaceutical Executive
- 2:30 AM · Science (News)2:30 AMBoy’s brain tumor tied to gene therapy — Science (News)
May 12, 2026
- 1:16 PM · Pharmaceutical Executive1:16 PM<![CDATA[Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal]]> — Pharmaceutical Executive
- 10:54 AM · Pharmaceutical Executive10:54 AM<![CDATA[Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration]]> — Pharmaceutical Executive